Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TAK 195

Next Previous
Drug Profile

TAK 195

Alternative Names: Sabin-inactivated poliovirus vaccine - Takeda; Sabin-IPV - Takeda; sIPV - Takeda; TAK-195

Latest Information Update: 18 Jul 2019

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Takeda
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Poliomyelitis

Most Recent Events

  • 18 Oct 2018 Suspended - Phase-I/II for Poliomyelitis (In adolescents, In children, In infants, Prevention, In adults) in Panama (IM) (NCT03092791)
  • 18 Oct 2018 Takeda terminates a phase I/II trial in Poliomyelitis (In adults, In children, Prevention, In infants, In adolscents) in Panama due to planned immunogenicity outcomes not reached (NCT03092791)
  • 07 Jun 2017 Phase-I/II clinical trials in Poliomyelitis (Prevention, In children, In infants, In adolescents, In adults) in Panama (IM) (NCT03092791)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top